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Abstract
Background. The main determinants of the level of leptin in human plasma are the fat mass and sex. In recent 
literature many papers have been published indicating the participation of leptin in the pathogenesis of essential 
hypertension. The aim of this study was to compare serum levels of leptin and evaluate its importance in the patho-
physiology of hypertension in obese men and women.
Material and methods. The study was conducted in a group of a total of 52 obese individuals (26 women and  
26 men) with newly diagnosed essential hypertension. The study protocol included blood sample collection for the 
measurements of biochemical parameters and hormone levels. Biochemical assays were performed using routine 
methods. Serum insulin was determined by immunoradiometric assay (IRMA). The index of insulin resistance 
(IR) was calculated using HOMA. Leptin, plasma renin activity (PRA) and plasma aldosterone concentration were 
determined by radioimmunoassay (RIA).
Results. No significant differences were found between women and men in terms of age, BMI, blood pressure, total 
cholesterol, LDL and fasting glucose. Men had slightly but significantly higher waist circumference. The group of 
women had significantly higher levels of leptin, insulin and insulin resistance, and a higher PRA and aldosterone 
levels than males. In the group studied, leptin significantly positively correlated with blood pressure, as well as with 
the concentration of aldosterone and renin both in women and in men. There was no similar relationship between 
leptin and insulin and the insulin resistance index.
Conclusions. 
1. Women with obesity and hypertension have higher levels of leptin than obese men with hypertension.
2. Reported correlations between plasma leptin concentration and blood pressure suggest that it is directly or indi-
rectly involved in the pathophysiology of hypertension in obese individuals regardless of gender.
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Introduction
The discovery of leptin in 1994 and the recognition 
of its effect on the cardiovascular system resulted in 
an increase in research activity in the role of this hor-
mone in the pathogenesis of cardiovascular diseases. 
In recent literature many papers have been published 
indicating the participation of leptin in the pathogen-
esis of essential hypertension [1–5].
So far the results have not enabled clear identifica-
tion of the mechanisms by which leptin would lead to 
an increase in blood pressure. Most researchers suggest 
that the main link between high blood pressure and 
leptin is the stimulation of the activity of the sympa-
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thetic nervous system [6, 7]. It was also shown that 
leptin is involved in the regulation of blood pressure 
due to its direct diuretic and natriuretic activity [8, 9].
The current literature suggests that obese people de-
velop leptin resistance. This phenomenon leads to the 
state of its relative deficiency, despite high concentra-
tions of plasma leptin [10]. The literature emphasizes 
the importance of leptin resistance in the pathogenesis 
of hypertension in obese people.
The main determinants of the level of leptin in hu-
man plasma are the fat mass and sex [11–13]. Sexual 
dimorphism in plasma concentrations of leptin has 
been documented. It has been shown that premeno-
pausal women have higher adiposity-adjusted leptin 
levels than women after the menopause and that both 
of these groups are characterized by a higher con-
centration of the hormone than men. The observed 
sex differences are attributed to the guiding role of 
oestrogen and the damping androgen effect on leptin 
secretion [14]. However, not all researchers agree with 
these suggestions [15, 16].
Due to the very heterogeneous criteria for the se-
lection of patients for published studies (BMI, sex, 
severity of hypertension, drugs), the results are often 
divergent, and difficult to interpret and compare.
The aim of this study was to compare plasma levels 
of leptin and evaluate its importance in the pathophys-
iology of hypertension in obese men and women.
Material and methods
The study was conducted in a group of a total of 52 
obese individuals (26 women and 26 men) with newly 
diagnosed essential hypertension grade 1 or 2 accor-
ding to Polish Society of Hypertension (PTNT) [17]. 
The diagnosis of hypertension was determined to give 
based on the measurements during two separate visits 
in an outpatient setting. Measurements were made by 
mercury manometer, with at least 15 minutes of rest 
in a sitting position, at intervals of at least 2 minu-
tes. At each visit blood pressure measurements were 
taken three times. The resultant average value of all 
measurements was taken for further calculation, in ac- 
cordance with the recommendation of the PTNT [17]. 
The study included patients that met the criteria of 
essential hypertension, after exclusion of secondary 
hypertension based on routine clinical, laboratory and 
radiological examinations [18].
The study protocol was approved by the Bioethics 
Committee of the Pomeranian Medical University in 
Szczecin.
The study protocol included blood sample collec-
tion for the measurements of biochemical parameters 
and hormone levels. Blood samples were collected at 
8 in the morning on an empty stomach, after at least 
8 hours of rest at night. 
Biochemical assays were performed using routine 
methods included the parameters of lipid metabolism 
and blood glucose.
Serum insulin was determined by immunoradio-
metric assay (IRMA). The index of insulin resistance 
(IR) was calculated using HOMA (glucose concentra-
tion [mml/l] x fasting insulin levels [uIU/ml]: 22.5).
Plasma leptin concentration was determined by ra-
dioimmunoassay (RIA). Plasma renin activity (PRA) 
and plasma aldosterone levels (ALDO) were deter-
mined using RIA.
Statistical analysis was performed using Statistica 
(StatSoft, Inc., USA).
The normality of the distribution was tested with 
the Shapiro-Wilk test. Independent variables with 
normal distribution were examined using t-tests, with 
evaluation of homogeneity of variance. Non-normally 
distributed variables were examined by non-parametric 
tests. Differences in the values of these variables between 
subgroups were evaluated using the non-parametric 
Kruskal-Wallis test and/or the Mann-Whitney U test.
For the assessment of the correlation between the 
parameters, Spearman’s rank correlation test was used. 
Values of p < 0.05 were taken as statistically significant.
Results
Table I provides a comparison of mean values of 
evaluated clinical, biochemical and hormonal param-
eters in men and women.
No significant differences were found between in 
terms of age, BMI, blood pressure, total cholesterol, 
LDL and fasting glucose. Men had slightly but signifi-
cantly higher waist circumference. The group of wom-
en had significantly higher levels of leptin, insulin and 
insulin resistance, and a higher plasma renin activity 
and aldosterone levels than males.
Table II presents correlations between leptin and 
evaluated parameters in the group of women.
In the group of obese women with hypertension, 
plasma leptin levels significantly positively correlated 
with BMI, blood pressure, and the concentration of 
aldosterone and renin. There were no similar rela-
tionships between leptin and insulin and the insulin 
resistance index.
Table III presents correlations between leptin and 
the evaluated parameters in the group of men.
In obese men with hypertension, as well as in women, 
plasma leptin levels correlated positively with the pa-
rameters of blood pressure and the concentration of 
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Table I. Comparison of mean ( ± SD) values of studied parameters between obese women and obese men with arterial hypertension
Variable Womenn = 26
Men
n = 26 p-value
Age (years) 35.5 ± 5.1 32.6 ± 5.3 ns
Body mass index [kg/m2] 33.1 ± 2.4 32.0 ± 1.7 ns
Waist circumference [cm] 100.1 ± 11.5 104.9 ± 3.2 < 0.001
Systolic blood pressure [mm Hg] 165.8 ± 13.1 161.5 ± 14.2 ns
Diastolic blood pressure [mm Hg] 100.8 ± 4.2 99.5 ± 3.4 ns
Mean blood pressure [mm Hg] 122.5 ± 6.6 121.7 ± 11.7 ns
Heart rate [f/min] 75.7 ± 8.9 68.3 ± 5.2 < 0.05
Total cholesterol [mg/dl] 238.2 ± 23.5 238.4 ± 13.5 ns
HDL [mg/dl] 42.9 ± 2.9 32.2 ± 3.8 < 0.001
LDL [mg/dl] 162.3 ± 23.7 170.0 ± 15.7 ns
Triglycerides [mg/dl] 181.0 ± 30.6 186.6 ± 17.5 < 0.025
Fasting glucose[mg/dl] 89.8 ± 7.1 89.2 ± 6.5 ns
Fasting insulin [uIU/ml] 12.0 ± 6.9 7.4 ± 3.6 < 0.05
IR 2.61 ± 1.43 1.61 ± 0.79 < 0.05
Leptin [ng/ml] 25.1 ± 8.7 9.3 ± 4.9 < 0.001
Plasma renin activity [ng/AI/ml/h] 3.22 ± 0.72 1.62 ± 0.64 < 0.001
Aldosterone [pg/ml] 257.4 ± 57.9 137.9 ± 44.9 < 0.001
HDL — high density lipoprotein, LDL — density lipoprotein, IR — insulin resistance
Table II. Correlations between leptin and other variables in obese women with arterial hypertension
Variable Variables R p-value
Leptin
Body mass index 0.54 < 0.005
Systolic blood pressure 0.85 < 0.001
Diastolic blood pressure 0.77 < 0.001
Mean blood pressure 0.92 < 0.001
Fasting insulin 0.30 ns
Insulin Resistance 0.32 ns
Plasma renin activity 0.86 < 0.001
Aldosterone 0.87 < 0.001
R refers to the Spearman rank correlation coefficient
Table III. Correlations between leptin and other variables in obese men with arterial hypertension
Variable Variables R p-value
Leptin
Body mass index 0.12 ns
Systolic blood pressure 0.60 < 0.001
Diastolic blood pressure 0.48 < 0.05
Mean blood pressure 0.49 < 0.05
Fasting insulin 0.22 ns
Insulin Resistance 0.22 ns
Plasma renin activity 0.84 < 0.001
Aldosterone 0.87 < 0.001
R refers to the Spearman rank correlation coefficient
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aldosterone and renin. There were no similar relation-
ships between BMI and leptin, and insulin and the 
insulin resistance index.
Discussion
The present study confirmed previously suggest-
ed dependence of the concentrations of leptin on 
patients’ gender [12, 19]. Women with obesity and 
hypertension had higher leptin levels than the same 
group of men. As demonstrated by in vivo studies, 
oestrogens may be responsible for these differences [14]. 
Mannucci et al. confirmed the regulatory effect of oes-
trogens on leptin secretion, indicating a significantly 
lower concentration of leptin in the early stage of the 
cycle, when the oestrogen level is reduced [20]. How-
ever, the mechanism of sexual dimorphism of leptin 
remains unclear.
In the present study, there is a statistically significant 
positive correlation between leptin and blood pressure 
both in women and in men with obesity. Our results 
indicate that hyperleptinaemia may be an important 
link between obesity and hypertension. Leptin, a pep-
tide hormone secreted by adipocytes in proportion 
to body fat mass, crosses the blood-brain barrier via 
a saturable transport system to activate its receptors in 
various regions of the central nervous system, especially 
in the hypothalamus and brainstem, to reduce appetite 
and increase energy expenditure [21].
Within physiological concentrations of leptin, its 
effect on the cardiovascular system results in the fall in 
blood pressure, whereas in conditions of chronic hy-
perleptinaemia accompanying obesity the pressor effect 
is dominating [22–24]. On the basis of the authors’ 
own observations, it can be assumed that leptin affects 
blood pressure, not only through its receptors, but also 
through indirect routes, e.g. through the renin-angio-
tensin-aldosterone system.
This explanation is supported by our study [25], 
which showed positive correlations of leptin concen-
tration with aldosterone and renin. In the current lit-
erature, it has been demonstrated that leptin is a new 
direct regulator of adrenal aldosterone synthase expres-
sion and an inducer of aldosterone production. These 
data demonstrate that leptin induces hypertension and 
endothelial dysfunction via aldosterone-dependent 
mechanisms in female mice and suggest that obesity 
leads to cardiovascular disease via sex-specific mecha-
nisms [25].
In the present study, both in women and men, there 
was no correlation between leptin and insulin or be-
tween leptin and the insulin resistance index. The liter-
ature reports on the subject are inconclusive. Similarly 
to the results from our study, Carantoni et al. showed 
no relationship between leptin and insulin concen-
trations and insulin resistance in the population of 
women [26]. In contrast, Kennedy et al. [27] and Sheu 
et al. [15] confirmed the existence of such a relation-
ship only in the group of men. A study performed by 
Sheu et al. also showed that leptin levels are higher in 
men diagnosed with essential hypertension compared 
with those without hypertension. The relationship was 
not confirmed in similar groups of women [15]. The 
resulting differences in the tests performed may be 
due to the complex relationship between leptin and 
insulin. They may also be the result of analysing dif-
ferent ethnic groups and populations with different 
clinical characteristics [15, 26]. Moreover, an elderly 
population participated in the study of Sheu et al. and 
most of the patients were taking antihypertensives [15]. 
Most authors suggest the need for extreme caution 
with mutual extrapolation of the results obtained in 
male and female populations as well as within the sur-
veyed ethnic groups [12, 16].
Conclusions
1. Women with obesity and hypertension have higher 
levels of leptin than obese men with hypertension.
2. Reported correlations between serum leptin and 
blood pressure suggest that it is directly or indirect-
ly involved in the pathophysiology of hypertension 
in obese individuals regardless of gender.
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